This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Talk:Autism spectrum: Difference between revisions
Jump to navigation
Jump to search
>David Hedlund Added https://www.ncbi.nlm.nih.gov/pubmed/12578238 |
>David Hedlund Added https://www.ncbi.nlm.nih.gov/pubmed/7890130 |
||
| Line 29: | Line 29: | ||
* [https://www.ncbi.nlm.nih.gov/pubmed/12223079 Biochemical aspects in autism spectrum disorders: updating the opioid-excess theory and presenting new opportunities for biomedical intervention.] | * [https://www.ncbi.nlm.nih.gov/pubmed/12223079 Biochemical aspects in autism spectrum disorders: updating the opioid-excess theory and presenting new opportunities for biomedical intervention.] | ||
* [https://www.ncbi.nlm.nih.gov/pubmed/27304256 Opioid peptides and gastrointestinal symptoms in autism spectrum disorders.] | * [https://www.ncbi.nlm.nih.gov/pubmed/27304256 Opioid peptides and gastrointestinal symptoms in autism spectrum disorders.] | ||
* [https://www.ncbi.nlm.nih.gov/pubmed/7890130 Endogenous opioids and opiate antagonists in autism: brief review of empirical findings and implications for clinicians.] | |||
==Serotonin== | ==Serotonin== | ||
Revision as of 01:31, 15 November 2018
 |
* What are we trying to say in that article?
|
@Clarity: Would you like to help me on this page (Kenan liked it but asked the questions that I added in the infobox)? --David Hedlund (talk) 01:44, 15 November 2018 (CET)
Cannabinoids
Endocannabinoids
- Endocannabinoid Signaling in Autism
- The Endocannabinoid System and Autism Spectrum Disorders: Insights from Animal Models
- Role of Endocannabinoids on Neuroinflammation in Autism Spectrum Disorder Prevention
- The Endocannabinoid System and Autism Spectrum Disorders: Insights from Animal Models.
Pharmacotherapy
For substances, see Cannabinoid.
Opioids
See also: [Opioid excess theory (Wikipedia)]
Endogenous opioids
- Opioid peptides and dipeptidyl peptidase in autism.
- μ opioid receptor, social behaviour and autism spectrum disorder: reward matters.
- Biochemical aspects in autism spectrum disorders: updating the opioid-excess theory and presenting new opportunities for biomedical intervention.
- Opioid peptides and gastrointestinal symptoms in autism spectrum disorders.
- Endogenous opioids and opiate antagonists in autism: brief review of empirical findings and implications for clinicians.
Serotonin
Endogenous serotonin
- Cortical serotonin 5-HT2A receptor binding and social communication in adults with Asperger's syndrome: an in vivo SPECT study.
- Elevated urine levels of bufotenine in patients with autistic spectrum disorders and schizophrenia.
Pharmacotherapy
For substances, see Serotonin.
Entacogens
- MDMA: MDMA-assisted therapy: A new treatment model for social anxiety in autistic adults.
- MDMA: Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study.